Thymosin Alpha-1
Thymosin Alpha-1 is a immune / longevity peptide. Typical research dosing is twice weekly, and the body of supporting research is clinical (approved in asia/europe).
What is Thymosin Alpha-1
You know the feeling. Every cold that goes around the office finds you. Every flight leaves you with a sore throat. You have read about immune peptides online and now you want to know what Thymosin Alpha-1 actually does and whether it makes sense for someone living in the Philippines.
Thymosin Alpha-1, often abbreviated TA-1, is a 28-amino acid peptide fragment of prothymosin alpha. It is naturally produced by your thymus gland, the small organ behind your breastbone that trains your T-cells. As you age, your thymus shrinks, and TA-1 production declines with it. The synthetic version is called thymalfasin, sold under the brand name Zadaxin in some Asian and European countries.
TA-1 was first sequenced in 1977 by Allan Goldstein at George Washington University. It has been used clinically for hepatitis B and C treatment in parts of Asia and Europe for decades. The mechanism is not immune suppression, it is immune regulation. TA-1 helps your immune system function more effectively without overstimulating it. Browse our full peptide library for related compounds.
In Philippines, TA-1 access is mainly through research-grade suppliers or international hospitals with hepatology departments. Zadaxin is not commonly stocked at standard pharmacies. Most expats sourcing TA-1 go through research-grade peptide suppliers or order from regional sources. For information on how this works, see the peptide legality guide.
How it works
Toll-Like Receptor Activation: TA-1 acts on TLR-2 and TLR-9 on dendritic cells and myeloid cells. This primes your innate immune system to recognize and respond to pathogens more effectively.
T-Cell Maturation: TA-1 stimulates the maturation of T-cells, specifically CD4+ helper T-cells and CD8+ cytotoxic T-cells. This is the same function your thymus performs naturally when it is healthy.
Natural Killer Cell Activation: TA-1 enhances the activity of NK cells, your first line of defense against virally infected cells and early-stage cancer cells.
Cytokine Modulation: TA-1 reduces the production of pro-inflammatory cytokines like IL-1 beta and TNF-alpha while promoting balanced immune signaling. This is regulation, not suppression.
Reported benefits
- Enhanced immune response to chronic viral infections (hepatitis B/C, HPV, CMV)
- Support for aging immune systems (immunosenescence)
- Adjunct therapy potential for autoimmune conditions
- Post-illness recovery support
- Cancer adjunct in clinical settings (with oncologist oversight)
- Reduced frequency of respiratory infections in some users
- Improved vaccine response in immunocompromised patients
Dosing protocol
| Phase | Dose | Frequency | Duration |
|---|---|---|---|
| Standard Protocol | 1.5 mg | Twice weekly (sub-q) | 4-12 weeks |
| Acute Support | 0.45 mg | Daily (sub-q) | 2-4 weeks |
| Maintenance | 1.5 mg | Once weekly | Ongoing as needed |
| Clinical (Hepatitis) | 1.6 mg | Twice weekly | 6-12 months |
Always start at the lowest effective dose and titrate up gradually.
Side effects
Common
- Mild injection site reaction (redness, minor swelling)
- Temporary fatigue in first few doses
- Mild headache reported by some users
Rare
- Temporary elevation in ALT liver enzymes (monitor if concerned)
- Flu-like symptoms during initial immune activation
Who should not use Thymosin Alpha-1
What to expect
Week 1-2
Most users feel nothing dramatic. Some report mild fatigue or flu-like symptoms as immune system activates. This typically resolves within days.
Week 3-4
Users focused on chronic infection support may notice subtle improvements. Energy levels often stabilize. Some report feeling "less susceptible" to whatever is going around.
Week 5-8
Cumulative immune benefits become more apparent. Users with chronic viral loads may see improvements in relevant bloodwork. General resilience improves.
Week 8+
Most users complete a cycle and assess. Some continue maintenance dosing. Others cycle off and return seasonally or when immune challenges arise.
FAQ
Is Thymosin Alpha-1 legal in the Philippines?
What is the typical dose of TA-1?
How is TA-1 different from TB-500?
Does TA-1 cause immune suppression?
How long does a TA-1 cycle last?
Can I stack TA-1 with other peptides?
Where can I buy TA-1 in the Philippines?
Where to get Thymosin Alpha-1 in the Philippines
See our community-verified supplier list with COA verification and cold-chain shipping to the Philippines.
Risk · Disclosure · Editorial Status
This page is editorial information for adults researching peptide therapy. It is not medical advice, not a prescription, and not an endorsement of any specific product, supplier, or protocol. Side effects can be serious and individual response varies. Talk to a licensed physician — ideally one with peptide-specific clinical experience — before starting any compound, adjusting a dose, or discontinuing therapy.
In the Philippines, GLP-1 medications are prescription-only under FDA Philippines regulation. Research-grade peptides occupy a regulatory gray area: import for personal research use is generally tolerated, but the Bureau of Customs reserves the right to inspect and detain shipments. Do not import for resale.
Editorial Status
Independent · Non-clinical
Affiliation
Not a clinic · Not a pharmacy
Last Updated
—